Publications by authors named "David Rinaldi"

Claim this Profile
J
Journal Keeping; Why it does Not Always Work.
David George Rinaldi

J Pastoral Care Counsel· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microscopic mechanism for shear thickening of non-Brownian suspensions.
Nicolas Fernandez, Roman Mani, David Rinaldi, Dirk Kadau, Martin Mosquet

Phys Rev Lett· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer.
Suresh Ramalingam, Michael C Perry, Renato V La Rocca, David Rinaldi, Preston S Gable

Cancer· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
Chandra P Belani, Suresh Ramalingam, Michael C Perry, Renato V LaRocca, David Rinaldi

J Clin Oncol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel and epirubicin as first-line treatment for patients with metastatic breast cancer: a Minnie Pearl Cancer Research Network Phase II trial.
John D Hainsworth, Denise A Yardley, David R Spigel, Anthony A Meluch, David Rinaldi

Cancer Invest· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of elderly non-small cell lung cancer patients with three different schedules of weekly paclitaxel in combination with carboplatin: subanalysis of a randomized trial.
Suresh Ramalingam, John Barstis, Michael C Perry, Renato V La Rocca, Sreenivasa R Nattam, David Rinaldi

J Thorac Oncol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen-independent prostate carcinoma.
David J Vaughn, Archie W Brown, W Graydon Harker, Sang Huh, Lance Miller, David Rinaldi

Cancer· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial.
Anthony A Meluch, F Anthony Greco, James R Gray, Melodie Thomas, Valerie M Sutton, David A Rinaldi

Cancer J· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation.
Chandra P Belani, John Barstis, Michael C Perry, Renato V La Rocca, Sreenivasa R Nattam, David Rinaldi

J Clin Oncol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer.
Charles S Fuchs, Melvin R Moore, Graydon Harker, Luis Villa, David Rinaldi

J Clin Oncol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of gemcitabine, administered as a standard and constant dose-rate infusion, in combination with paclitaxel in patients with advanced solid tumors (LOA-2).
David A Rinaldi, Nancy A Lormand, Joseph E Brierre, James L Cole, M Patrick Stagg

Am J Clin Oncol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II trial of topotecan and gemcitabine in patients with previously treated, advanced nonsmall cell lung carcinoma.
David A Rinaldi, Nancy A Lormand, Joseph E Brierre, James L Cole, Brian C Barnes

Cancer· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis